María del Carmen Plaza‐Calonge

Author

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research

Also Known As

María del Carmen Plaza-Calonge, María del Carmen Plaza‐Calonge

Publications

452

Citations

H-Index

Concepts

All Affiliations

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research Universidad de Granada Vall d'Hebron Institut de Recerca Vall d'Hebron Hospital Universitari Vall d'Hebron Institute of Oncology

About

María del Carmen Plaza‐Calonge is an author at Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	324
2	Cell Biology	6	6	324
3	Natural Sciences	2	2	116
4	Immunology	2	2	125
5	Molecular Biology	2	2	160

María del Carmen Plaza‐Calonge

Publications

444

Citations

H-Index

Page 1

	Year	Citations
Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion Juan Carlos Rodríguez‐Manzaneque, Darren R. Carpizo, María del Carmen Plaza‐Calonge, The International Journal of Biochemistry & Cell Biology Cell AdhesionMolecular BiologyCell-matrix InteractionAdamts1 Provokes DefectsMatrix Biology	2008	87
Identification of substrates of the extracellular protease ADAMTS1 by DIGE proteomic analysis Françesc Canals, Núria Colomé, Cristina Suárez Ferrer, PROTEOMICS ImmunologyProteasomeMolecular BiologyMatrix ProteasesInflammation	2006	73
A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification Clara Bueno, Rosa Montes, Gustavo J. Melen, Cell Research Hematological MalignancyHuman Esc ModelMixed-phenotype Acute LeukemiaHematologyImmunology	2012	52
ADAMTS1 Contributes to the Acquisition of an Endothelial-like Phenotype in Plastic Tumor Cells Carmen Casal, Antoni X. Torres‐Collado, María del Carmen Plaza‐Calonge, Cancer Research Biological MicroenvironmentsPlastic Tumor CellsCancer BiologyTumor BiologyAngiogenesis	2010	52
Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen‐1 and nidogen‐2 Estefanía Martino‐Echarri, Rubén Fernández‐Rodríguez, Francisco Javier Rodríguez‐Baena, International Journal of Cancer PathologyHuman Breast CarcinomaCancer BiologyTumor BiologyAngiogenesis	2013	43
Gallic Acid: A Natural Phenolic Compound Exerting Antitumoral Activities in Colorectal Cancer via Interaction with G-Quadruplexes Victoria Sánchez-Martín, María del Carmen Plaza‐Calonge, Ana Soriano‐Lerma, Cancers	2022	37
ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response Francisco Javier Rodríguez‐Baena, Silvia Redondo-García, Carlos Peris-Torres, Scientific Reports	2018	27
Stroma-derived but not tumor ADAMTS1 is a main driver of tumor growth and metastasis Rubén Fernández‐Rodríguez, Francisco Javier Rodríguez‐Baena, Estefanía Martino‐Echarri, Oncotarget	2016	21
Extracellular Protease ADAMTS1 Is Required at Early Stages of Human Uveal Melanoma Development by Inducing Stemness and Endothelial-Like Features on Tumor Cells Carlos Peris-Torres, María del Carmen Plaza‐Calonge, Raúl López-Domínguez, Cancers	2020	21
ADAMTS1 Supports Endothelial Plasticity of Glioblastoma Cells with Relevance for Glioma Progression Orlando Serrano-Garrido, Carlos Peris-Torres, Silvia Redondo-García, Biomolecules Glioma ProgressionCancer BiologyGliomaTumor BiologyNeuro-oncology	2020	17

Page 1